LLY240719C1025000
- 0.01
- -0.06-85.71%
Eli Lilly and Co Newsroom
Rivals Emerge to Ozempic and Zepbound -- but With a Lag -- Heard on the Street -- WSJ
By David Wainer The two dominant players in the obesity market will eventually make way for a few more competitors. Just don't expect the latecomers to be equals to Eli Lilly and Novo Nordisk. There
Express News | Eli Lilly: Tirzepatide Injection Has Been Approved by China's Medical Products Regulator for Long-Term Weight Management
Famous fund manager Li Yaozhu's second quarter report is released! Apple (AAPL.US) is a new top ten heavy stock in the portfolio, increasing investment in Hong Kong stocks with high dividends.
On July 18, 2023, the famous fund hold position manager Li Yaozhu, who won the championship in the public sale on the whole market, released the second quarter report of Guangfa Global Select Stocks fund and Guangfa New Starting Point fund on the Hong Kong and Shenzhen stock exchanges.
Express News | Eli Lilly & Co : HSBC Raises Target Price to $1100 From $880
Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Thursday, major U.S. stock indices were down, with the Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03, the S&P 500 falling almost 0.8% to 5,544.59, and the Nasdaq decreasing 0.7% to 17,871.22.
Healthcare Stocks at an 'Inflection Point,' Analyst Says
Jobless Claims, Healthcare, Small Caps: Trading Takeaways
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.
Top 20 US stock trading volume on July 18: a well-known analyst said that orders for the Apple iPhone 16 may not have increased.
On Thursday, Nvidia, the top-performing stock in trading volume, rose 2.8%, partially recovering from the huge losses suffered on Wednesday, with a transaction value of $38.113 billion. As of the close of trading on Thursday, the stock had fallen more than 6.3% and may record a decline this week. Tesla, in second place, rose 0.29%, with a transaction value of $27.806 billion. According to the California New Car Dealers Association (CNCDA), Tesla's sales in California in the second quarter of 2024 sharply fell by 24%. The CNCDA reported on Thursday that Tesla's car registration in California has dropped 17% so far this year compared to last year, despite Tesla's.
Eli Lilly and Co Options Spot-On: On July 18th, 116.55K Contracts Were Traded, With 311.5K Open Interest
On July 18th ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 116.55K options for the day, of which put options accounted for 44.29% of the total transactions,
Are We on the Brink of Another Nasdaq Crash?
By Joseph Adinolfi This bearish strategist says there is a bubble in artificial-intelligence stocks, and it could be about to burst The Nasdaq's troubles might only be getting started, as technology
Truist Financial Initiates Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,000
Truist Financial analyst Richard Newitter initiates coverage on $Eli Lilly and Co(LLY.US)$ with a buy rating, and sets the target price at $1,000.According to TipRanks data, the analyst has a
Trending Stocks Today | Onconetix Soars 70.13%
July 18th - US stocks trending in regular trading hours.Gainers: $Onconetix(ONCO.US)$ surges 70.13% to $0.25 with a turnover of $104.34 million. $Silo Pharma(SILO.US)$ soars 55.77% to $3.51 with a
Top 10 S&P 500 Stocks Down More Than 5% From Last Week
Eli Lilly's Stock Plunges as Investors Eye Obesity-drug Competition
Eli Lilly & Co.'s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying competition among obesity-drug developers.
Eli Lilly, Novo Extend Muti-day Decline in Rare Selloff
Shares of weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) extended a multi-day decline on Thursday, losing billions of dollars in market capitalization for two of the world’s biggest companies.
What's Going On With Eli Lilly And Company Shares Thursday?
Eli Lilly and Company (NYSE:LLY) stock is moving lower on Thursday on possible continued weakness after recent weight loss data from Roche.What To Know: On Wednesday, Roche announced positive Phase
Teva's Migraine Treatment Found Effective For Children As Young As 6
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced on Thursday topline results from its Phase 3 SPACE study evaluating the efficacy of Ajovy (fremanezumab) for the prevention of episodic
Express News | Shares of Weight Loss Stocks Are Trading Lower, Possibly on Continued Weakness Following Recent Weight Loss Data From Roche, Which Could Cause Competition Concerns for Companies in the Space
Express News | Eli Lilly Shares Down 5.4% to Over One Month Low